Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent studies have suggested an association between hyperuricemia and adverse renal outcomes in nondiabetic populations. Data on the relationship between hyperuricemia and the risk of incident chronic kidney disease (CKD) in type 2 diabetic patients with normal or near-normal kidney function are lacking. We determined whether baseline serum uric acid levels predict the subsequent development of CKD in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We followed 1,449 type 2 diabetic patients with normal kidney function and without overt proteinuria for 5 years for the occurrence of incident CKD (defined as overt proteinuria or estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2). RESULTS: During a 5-year follow-up period, 194 (13.4%) patients developed incident CKD. The cumulative incidence of CKD was significantly greater in patients with hyperuricemia than in those without hyperuricemia (29.5 vs. 11.4%, P < 0.001). In univariate logistic regression analysis, the presence of hyperuricemia roughly doubled the risk of developing CKD (odds ratio [OR] 2.55 [95% CI 1.71–3.85], P < 0.001). After adjusting for age, sex, BMI, smoking status, diabetes duration, systolic blood pressure, antihypertensive treatment, insulin therapy, HbA1c, eGFR, and albuminuria, hyperuricemia was associated with an increased risk of incident CKD (adjusted OR 2.10 [1.16–3.76], P < 0.01). In continuous analyses, a 1-SD increment in the serum uric acid level was significantly associated with a 21% increased risk of CKD. CONCLUSIONS: In type 2 diabetic individuals with preserved kidney function, hyperuricemia seems to be an independent risk factor for the development of incident CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperuricemia may induce kidney inflammation and has been reported to be a risk factor for incident DKD in T2DM (43).”
From SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation (2021) · cites this paper as [43]
In the citing paper
“Hyperuricemia has been associated with kidney inflammation, and various observational studies documented a strong linear association between higher plasma uric acid levels and progressive kidney function loss (Zoppini et al., 2012).”
From A kidney perspective on the mechanism of action of sodium glucose co-transporter 2 inhibitors (2021) · cites this paper as Zoppini et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 1×
“Nonetheless, current GFR estimates facilitate the detection, evaluation, and management of CKD, and many organizations recommend the use of prediction equations for the evaluation of kidney function in large epidemiologic studies and in clinical practice (1,10,25,26).”
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834 · cited 1×
“Two small prospective, randomized, controlled trials involving nondiabetic and diabetic patients with hyperuricemia and CKD, who were randomly assigned to treatment with allopurinol or to continue with the usual therapy for 12–24 months, demonstrated that the allopurinol group showed less kidney dysfunction compared w…”
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834 · cited 1×
“Two small prospective, randomized, controlled trials involving nondiabetic and diabetic patients with hyperuricemia and CKD, who were randomly assigned to treatment with allopurinol or to continue with the usual therapy for 12–24 months, demonstrated that the allopurinol group showed less kidney dysfunction compared w…”
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826 · cited 2×
“Kidney damage in hyperuricemic rats is not dependent on blood pressure and instead involves the renin-angiotensin and cyclooxygenase-2 systems (29,30).”
Niskanen, L. K., Laaksonen, D. E., Nyyssönen, K., Alfthan, G., Lakka, H.-M., Lakka, T. A., & Salonen, J. T. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1546 · Cited by 666
Elevated Uric Acid Increases the Risk for Kidney Disease
Obermayr, R. P., Temml, C., Gutjahr, G., Knechtelsdorfer, M., Oberbauer, R., & Klauser-Braun, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010080 · Cited by 647
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K., & Takishita, S. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00934-5 · Cited by 526
Uric Acid and Incident Kidney Disease in the Community
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101075 · Cited by 462
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
Self-citationHickman, C. P., & Trump, B. F. (1969) · Fish Physiology · doi:10.1016/s1546-5098(08)60083-7 · Cited by 414
ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.691 · Cited by 386
Chen, J., Chuang, S., Chen, H., Yeh, W., & Pan, W. (2009) · Arthritis Care & Research · doi:10.1002/art.24164 · Cited by 375
Muggeo, M., Zoppini, G., Bonora, E., Brun, E., Bonadonna, R. C., Moghetti, P., & Verlato, G. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.45 · Cited by 263 · cited 3×
“METHODSdThe study was performed within the framework of the Verona Diabetes Study, an observational longitudinal study on chronic complications in type 2 diabetic outpatients attending the diabetes clinic at the University Hospital of Verona (24).”
InfluentialSelf-citationAssociation of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Bellomo, G., Venanzi, S., Verdura, C., Saronio, P., Esposito, A., & Timio, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.019 · Cited by 260
The paradoxical relationship between serum uric acid and cardiovascular disease
Lippi, G., Montagnana, M., Franchini, M., Favaloro, E. J., & Targher, G. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.02.024 · Cited by 247
Self-citationFicociello, L. H., Rosolowsky, E. T., Niewczas, M. A., Maselli, N. J., Weinberg, J. M., Aschengrau, A., Eckfeldt, J. H., Stanton, R. C., Galecki, A. T., Doria, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0227 · Cited by 218 · cited 2×
“Overall, our findings are corroborated by previous observations of two small prospective studies showing a strong, graded relationship between elevated uric acid levels and the risk of early decline in renal function in nonproteinuric patients with type 1 diabetes (21,22).”
Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes
Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J., & Parving, H.-H. (2009) · Diabetes · doi:10.2337/db09-0014 · Cited by 215
Miao, Y., Ottenbros, S. A., Laverman, G. D., Brenner, B. M., Cooper, M. E., Parving, H.-H., Grobbee, D. E., Shahinfar, S., de Zeeuw, D., & Lambers Heerspink, H. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.171488 · Cited by 182 · cited 6×
“These findings support the view that serum uric acid may be a modifiable risk factor for renal disease in type 2 diabetic patients (23).”
InfluentialSturm, G., Kollerits, B., Neyer, U., Ritz, E., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.01.006 · Cited by 170
Rosolowsky, E. T., Ficociello, L. H., Maselli, N. J., Niewczas, M. A., Binns, A. L., Roshan, B., Warram, J. H., & Krolewski, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04271007 · Cited by 161 · cited 2×
“Overall, our findings are corroborated by previous observations of two small prospective studies showing a strong, graded relationship between elevated uric acid levels and the risk of early decline in renal function in nonproteinuric patients with type 1 diabetes (21,22).”
Has the incidence of end-stage renal disease in the USA and other countries stabilized?
Eggers, P. W. (2011) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283454319 · Cited by 152
Zoppini, G., Targher, G., Negri, C., Stoico, V., Perrone, F., Muggeo, M., & Bonora, E. (2009) · Diabetes Care · doi:10.2337/dc09-0625 · Cited by 141 · cited 1×
“More details about the study design and recruitment methods have been reported elsewhere (9).”
Self-citationUric Acid Levels Predict Future Development of Chronic Kidney Disease
Sonoda, H., Takase, H., Dohi, Y., & Kimura, G. (2011) · American Journal of Nephrology · doi:10.1159/000326848 · Cited by 108
Serum Uric Acid as a New Player in the Development of Diabetic Nephropathy
Hovind, P. H., Rossing, P. R., Johnson, R. J., & Parving, H. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.10.024 · Cited by 81 · cited 1×
“Kidney damage in hyperuricemic rats is not dependent on blood pressure and instead involves the renin-angiotensin and cyclooxygenase-2 systems (29,30).”
Ioachimescu, A. G., Brennan, D. M., Hoar, B. M., Kashyap, S. R., & Hoogwerf, B. J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02302.x · Cited by 44
Uric Acid, CKD and Cardiovascular Disease: Confounders, Culprits and Circles
Tangri, N., & Weiner, D. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.06.004 · Cited by 44 · cited 1×
“Hyperuricemia also is largely prevalent in patients with chronic kidney disease (CKD) (10,11).”
The Kidney: Diabetic Nephropathy
Vats, A. N., & DeRubertis, F. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-310-0:409 · Cited by 18
Research works printed but not linked: 1
- Brenner, 2004, Diabetic nephropathy, 1777
Cited by
Uric acid and chronic kidney disease: which is chasing which?
Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D.-H., & Ritz, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft029 · Cited by 654
Serum uric acid and the risk of cardiovascular and renal disease
Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., & Mancia, G. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000701 · Cited by 463
“This finding is supported by the results of a 5-year observational study in 1449 patients with type 2 diabetes and normal kidney function [84].”
ResultHyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., & Tsioufis, K. P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.006 · Cited by 435
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
Li, L., Yang, C., Zhao, Y., Zeng, X., Liu, F., & Fu, P. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-122 · Cited by 371
Metadata
- Authors
- Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E.
- Affiliations
- University of Verona (IT)
- Division of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado
- Corresponding author
- Targher, Giovanni
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-12-09
- Volume
- 35
- Issue
- 1
- Pages
- 99-104
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3241303
- OpenAlex
- W2151157525
- Cited by
- 274
- References
- 35
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 19 · 2023: 22 · 2022: 21 · 2021: 27 · 2020: 19 · 2019: 24 · 2018: 24 · 2017: 19 · 2016: 14 · 2015: 24 · 2014: 13 · 2013: 14 · 2012: 11
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- serum uric acid, hyperuricemia, chronic kidney disease, type 2 diabetes, preserved renal function, incident CKD risk, estimated glomerular filtration rate, albuminuria, proteinuria, risk factors
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Italy, Kidney Failure, Chronic, Male, Middle Aged, Risk Factors, Uric Acid, Hyperuricemia, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
